BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18623928)

  • 21. Tissue reaction to an implantable identification device in mice.
    Rao GN; Edmondson J
    Toxicol Pathol; 1990; 18(3):412-6. PubMed ID: 2267501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Search for "indicators" of neoplastic conversion in vitro.
    Sanford KK; Barker BE; Woods MW; Parshad R; Law LW
    J Natl Cancer Inst; 1967 Oct; 39(4):705-33. PubMed ID: 18623932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Super competition as a possible mechanism to pioneer precancerous fields.
    Rhiner C; Moreno E
    Carcinogenesis; 2009 May; 30(5):723-8. PubMed ID: 19126656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
    Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
    Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Two-stage carcinogenesis induced by foreign bodies].
    Moĭzhess TG; Vasil'ev IuM
    Biull Eksp Biol Med; 1986 May; 101(5):604-5. PubMed ID: 3708147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
    Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of premalignant melanosis of the vagina recurring urethral orifice and intrapelvic retroperitoneum with malignant transformation].
    Fukui S; Nakai Y; Hajikano S; Takahashi E; Hirayama A; Fujimoto K; Hirao Y
    Hinyokika Kiyo; 2008 Oct; 54(10):681-4. PubMed ID: 19048936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foreign-body tumorigenesis: number, distribution, and cell density of preneoplastic clones.
    Thomassen MJ; Buoen LC; Brand KG
    J Natl Cancer Inst; 1975 Jan; 54(1):203-7. PubMed ID: 1113301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of thalidomide on DMBA-induced oral carcinogenesis in hamster with respect to angiogenesis.
    Yang Y; Ge JP; Zhou ZT
    J Oral Pathol Med; 2009 May; 38(5):455-62. PubMed ID: 19141066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the karyotypic origin and evolution of cancer cells.
    Nicholson JM; Duesberg P
    Cancer Genet Cytogenet; 2009 Oct; 194(2):96-110. PubMed ID: 19781442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue integration of polyacrylamide hydrogel: an experimental study of periurethral, perivesical, and mammary gland tissue in the pig.
    Christensen LH; Nielsen JB; Mouritsen L; Sørensen M; Lose G
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S68-77; discussion S77. PubMed ID: 18547185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression.
    Simiantonaki N; Taxeidis M; Jayasinghe C; Kurzik-Dumke U; Kirkpatrick CJ
    BMC Cancer; 2008 Nov; 8():320. PubMed ID: 18983642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory reaction induced by agarose implants reduced by adding adrenal cells to the polymer.
    Cadic-Amadeuf CM; Vitiello S; Baquey CV; Dupuy BJ
    ASAIO J; 1992; 38(3):M386-9. PubMed ID: 1457888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
    Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
    Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of inducible nitric oxide synthase gene on tumor progression.
    Tatemichi M; Ogura T; Esumi H
    Eur J Cancer Prev; 2009 Feb; 18(1):1-8. PubMed ID: 19077558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosome abnormalities as primary events in human malignant disease: evidence from marker chromosomes.
    Atkin NB; Baker MC
    J Natl Cancer Inst; 1966 Mar; 36(3):539-57. PubMed ID: 18630328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of a newly designed single-stage craniofacial implant: a pilot study.
    Khamis MM; Medra A; Gauld J
    J Prosthet Dent; 2008 Nov; 100(5):375-83. PubMed ID: 18992571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologic effects of implant debris.
    Hallab NJ; Jacobs JJ
    Bull NYU Hosp Jt Dis; 2009; 67(2):182-8. PubMed ID: 19583551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.